Linscomb Wealth’s Amgen AMGN Stock Holding History

Linscomb Wealth’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11M	Sell	31,399 -7,494	-19%	-$2.67M	0.49%	41
2025 Q4	$12.7M	Buy	38,893 +152	+0.4%	+$48.2K	0.53%	40
2025 Q3	$10.9M	Buy	38,741 +637	+2%	+$185K	0.47%	50
2025 Q2	$10.6M	Buy	38,104 +111	+0.3%	+$31.4K	0.49%	45
2025 Q1	$11.8M	Buy	37,993 +4,050	+12%	+$1.2M	0.59%	32
2024 Q4	$8.85M	Buy	33,943 +396	+1%	+$117K	0.44%	53
2024 Q3	$10.8M	Sell	33,547 -484	-1%	-$158K	0.54%	38
2024 Q2	$10.6M	Sell	34,031 -729	-2%	-$214K	0.55%	33
2024 Q1	$9.88M	Sell	34,760 -546	-2%	-$160K	0.51%	42
2023 Q4	$10.2M	Sell	35,306 -3,846	-10%	-$1.05M	0.56%	35
2023 Q3	$10.5M	Sell	39,152 -3,052	-7%	-$762K	0.62%	26
2023 Q2	$9.37M	Sell	42,204 -1,980	-4%	-$459K	0.51%	46
2023 Q1	$10.7M	Sell	44,184 -856	-2%	-$210K	0.56%	40
2022 Q4	$11.8M	Buy	45,040 +332	+0.7%	+$89K	0.6%	31
2022 Q3	$10.1M	Buy	44,708 +770	+2%	+$187K	0.61%	35
2022 Q2	$10.7M	Buy	43,938 +686	+2%	+$168K	0.61%	36
2022 Q1	$10.5M	Buy	43,252 +2,286	+6%	+$525K	0.5%	46
2021 Q4	$9.22M	Buy	40,966 +1,022	+3%	+$216K	0.44%	55
2021 Q3	$8.49M	Buy	39,944 +1,220	+3%	+$281K	0.44%	59
2021 Q2	$9.44M	Buy	38,724 +1,489	+4%	+$366K	0.48%	52
2021 Q1	$9.26M	Buy	37,235 +1,226	+3%	+$293K	0.5%	49
2020 Q4	$8.28M	Buy	36,009 +815	+2%	+$188K	0.49%	48
2020 Q3	$8.95M	Buy	35,194 +773	+2%	+$192K	0.62%	30
2020 Q2	$8.12M	Buy	34,421 +3,873	+13%	+$884K	0.59%	31
2020 Q1	$6.19M	Buy	30,548 +1,764	+6%	+$385K	0.55%	32
2019 Q4	$6.94M	Buy	28,784 +1,079	+4%	+$238K	0.45%	35
2019 Q3	$5.36M	Buy	27,705 +1,248	+5%	+$240K	0.43%	40
2019 Q2	$4.88M	Buy	26,457 +584	+2%	+$105K	0.4%	46
2019 Q1	$4.92M	Buy	25,873 +444	+2%	+$84.8K	0.41%	43
2018 Q4	$4.95M	Buy	25,429 +428	+2%	+$83.5K	0.47%	37
2018 Q3	$5.18M	Buy	25,001 +365	+1%	+$71.9K	0.43%	37
2018 Q2	$4.55M	Buy	24,636 +1,010	+4%	+$179K	0.39%	42
2018 Q1	$4.03M	Buy	23,626 +184	+0.8%	+$33.8K	0.34%	47
2017 Q4	$4.08M	Buy	23,442 +596	+3%	+$105K	0.33%	51
2017 Q3	$4.26M	Buy	22,846 +426	+2%	+$75.5K	0.37%	48
2017 Q2	$3.86M	Sell	22,420 -149	-0.7%	-$24.2K	0.35%	52
2017 Q1	$3.7M	Buy	22,569 +1,788	+9%	+$297K	0.34%	52
2016 Q4	$3.04M	Buy	20,781 +1,972	+10%	+$297K	0.28%	60
2016 Q3	$3.14M	Buy	18,809 +2,262	+14%	+$383K	0.31%	50
2016 Q2	$2.52M	Buy	16,547 +58	+0.4%	+$9.02K	0.25%	58
2016 Q1	$2.47M	Buy	16,489 +704	+4%	+$105K	0.27%	62
2015 Q4	$2.56M	Buy	15,785 +781	+5%	+$123K	0.29%	57
2015 Q3	$2.08M	Buy	15,004 +510	+4%	+$80.4K	0.24%	65
2015 Q2	$2.23M	Buy	14,494 +523	+4%	+$83.8K	0.24%	67
2015 Q1	$2.23M	Buy	13,971 +901	+7%	+$142K	0.24%	72
2014 Q4	$2.08M	Buy	13,070 +559	+4%	+$87.1K	0.23%	77
2014 Q3	$1.76M	Buy	12,511 +10,467	+512%	+$1.37M	0.19%	84
2014 Q2	$242K	Sell	2,044 -72	-3%	-$8.34K	0.03%	238
2014 Q1	$261K	Buy	2,116 +188	+10%	+$22.8K	0.03%	226
2013 Q4	$220K	Sell	1,928 -1,000	-34%	-$114K	0.03%	211
2013 Q3	$328K	Sell	2,928 -75	-2%	-$8.13K	0.04%	176
2013 Q2	$296K	Buy	+3,003	New	+$312K	0.04%	184

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Linscomb Wealth's AMGN Position: Q1 2026 in Review

Linscomb Wealth reduced its Amgen (AMGN) stake by 19% in Q1 2026, selling an estimated $2.67M and leaving 31,399 shares worth $11M. The position accounts for 0.49% of the portfolio, ranked #41.

Linscomb Wealth first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.7M in Q4 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Linscomb Wealth held 31,399 shares of Amgen worth $11M as of Q1 2026.
Linscomb Wealth sold 7,494 Amgen shares in Q1 2026, an estimated $2.67M.
Amgen made up 0.49% of Linscomb Wealth's portfolio in Q1 2026, its #41 holding.
Linscomb Wealth first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
Linscomb Wealth's Amgen position peaked at $12.7M in Q4 2025.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Linscomb Wealth's 13F filing for Q1 2026, filed 11 May 2026.